{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T21:23:10Z","timestamp":1783286590188,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.diagmicrobio.2023.116048","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T03:26:03Z","timestamp":1690946763000},"page":"116048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-7695","authenticated-orcid":false,"given":"Caroline","family":"Gastaldi Guerrieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Teixeira Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anazi","family":"Ferreira da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luis","family":"Souza dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00eania Val\u00e9ria","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Cruz Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.diagmicrobio.2023.116048_bib0001","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/cid\/cix669","article-title":"Practice guidelines for the diagnosis and management of infectious diarrhea","volume":"65","author":"Shane","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116048_bib0002","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/S2214-109X(19)30541-8","article-title":"Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study","volume":"8","author":"Levine","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116048_bib0003","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/CMR.00022-13","article-title":"Recent advances in understanding enteric pathogenic Escherichia coli","volume":"26","author":"Croxen","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116048_bib0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1574-6968.2005.00005.x","article-title":"Pathogenesis of enteroaggregative Escherichia coli infection","volume":"254","author":"Harrington","year":"2005","journal-title":"FEMS Microbiol Lett"},{"issue":"19","key":"10.1016\/j.diagmicrobio.2023.116048_bib0005","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany","volume":"365","author":"Frank","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116048_bib0006","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.00112-13","article-title":"Epidemiology and clinical manifestations of enteroaggregative Escherichia coli","volume":"27","author":"Jensen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0007","series-title":"Escherichia coli in the Americas","first-page":"27","article-title":"Enteroaggregative Escherichia coli (EAEC)","author":"Elias","year":"2016"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116048_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/513809","article-title":"Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells","volume":"177","author":"Steiner","year":"1998","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116048_bib0009","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.2010.09-0792","article-title":"Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition","volume":"83","author":"Opintan","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.micpath.2015.06.002","article-title":"Current perspectives in pathogenesis and antimicrobial resistance of enteroaggregative Escherichia coli","volume":"85","author":"Kong","year":"2015","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2023.116048_bib0011","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/JCM.41.10.4525-4530.2003","article-title":"Etiology of acute diarrhea in adults in Southwestern Nigeria","volume":"41","author":"Okeke","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116048_bib0012","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/00365540802641856","article-title":"Multidrug resistant enteroaggregative Escherichia coli diarrhea in rural southern Indian population","volume":"41","author":"Raju","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116048_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijid.2010.10.002","article-title":"Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern","volume":"15","author":"Aslani","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2023.116048_bib0014","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3855\/jidc.4077","article-title":"Enteroaggregative Escherichia coli in diarrheic children in Egypt: molecular characterization and antimicrobial susceptibility","volume":"8","author":"Ali","year":"2014","journal-title":"J Infect Dev Ctries"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116048_bib0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116048_bib0016","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1574-695X.2010.00702.x","article-title":"The yddV-dos operon controls biofilm formation through the regulation of genes encoding curli fibers' subunits in aerobically growing Escherichia coli","volume":"59","author":"Tagliabue","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116048_bib0017","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","author":"Ceri","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0018","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.42.5.1915-1922.2004","article-title":"Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis","volume":"5","author":"Moskowitz","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.116048_bib0019","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2010.71","article-title":"Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening","volume":"5","author":"Harrison","year":"2010","journal-title":"Nat Protoc"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2023.116048_bib0020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1469-0691.12651","article-title":"Antimicrobial susceptibility testing in biofilm-growing bacteria","volume":"20","author":"Maci\u00e1","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2023.116048_bib0021","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2958.2001.02512.x","article-title":"Roles for Fis and Yafk in biofilm formation by enteroaggregative Escherichia coli","volume":"41","author":"Sheikh","year":"2001","journal-title":"Mol Microbiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2023.116048_bib0022","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","article-title":"Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci","volume":"115","author":"Stepanovi\u0107","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0023","series-title":"Performance Standards for antimicrobial susceptibility testing: M:100-ED31. CLSI","year":"2021"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116048_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116048_bib0026","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/jac\/dkn108","article-title":"High rate of resistance to locally used antibiotics among enteric bacteria from children in Northern Ghana","volume":"61","author":"Djie-Maletz","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116048_bib0027","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1574-6968.2010.02160.x","article-title":"Prevalence of Escherichia coli among samples collected from the genital tract in pregnant and nonpregnant women: relationship with virulence","volume":"314","author":"Guiral","year":"2011","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0028","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2147\/IDR.S167271","article-title":"Antibiotic resistance pattern and molecular characterization of extended-spectrum \u03b2-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran","volume":"11","author":"Amim","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0029","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1471-2334-13-418","article-title":"Genotypic and phenotypic analysis of diarrheagenic Escherichia coli strains isolated from Brazilian children living in low socioeconomic level communities","volume":"13","author":"Lozer","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116048_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol"},{"issue":"9276","key":"10.1016\/j.diagmicrobio.2023.116048_bib0031","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116048_bib0032","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0033","article-title":"The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms","volume":"2013","author":"Kwiencinska-Pir\u00f3g","year":"2013","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2023.116048_bib0034","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","article-title":"The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin","volume":"15","author":"Tseng","year":"2013","journal-title":"Environ Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.116048_bib0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000398","article-title":"Biofilms","volume":"2","author":"L\u00f3pez","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2023.116048_bib0036","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/AAC.00454-09","article-title":"Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes","volume":"53","author":"May","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2023.116048_bib0037","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1128\/AEM.02949-08","article-title":"Increased antibiotic resistance of Escherichia coli in mature biofilms","volume":"75","author":"Ito","year":"2009","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2023.116048_bib0038","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1600-0463.2010.02636.x","article-title":"Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis","volume":"118","author":"Ferreira","year":"2010","journal-title":"APMIS"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2023.116048_bib0039","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/AAC.00126-11","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms","volume":"55","author":"Hengzhuang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0040","first-page":"27","article-title":"Enteroaggregative Escherichia coli","volume":"416","author":"Jenkins","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0041","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.2147\/IDR.S258355","article-title":"In-vitro investigation of antibiotics efficacy against uropathogenic Escherichia coli biofilms and antibiotic induced biofilm formation at sub-minimum inhibitory concentration of ciprofloxacin","volume":"13","author":"Rafaque","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116048_bib0042","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijantimicag.2007.05.005","article-title":"Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin\/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilm","volume":"30","author":"Rodr\u00edguez-Mart\u00ednez","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"23","key":"10.1016\/j.diagmicrobio.2023.116048_bib0043","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1128\/JB.183.23.6746-6751.2001","article-title":"Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials","volume":"183","author":"Spoering","year":"2001","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2023.116048_bib0044","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/jcm.12.5.690-694.1980","article-title":"Aberrant forms of Escherichia coli in blood cultures: in vitro reproduction of an in vivo observation","volume":"12","author":"Magnussen","year":"1980","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116048_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cyto.990030211","article-title":"The effect of some beta-lactam antibiotics on Escherichia coli studied by flow cytometry","volume":"3","author":"Martinez","year":"1982","journal-title":"Cytometry"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2960194","article-title":"SEM analysis of surface impact on biofilm antibiotic treatment","volume":"2017","author":"Gomes","year":"2017","journal-title":"Scanning"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116048_bib0047","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/AAC.44.3.682-687.2000","article-title":"Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure","volume":"44","author":"Wickens","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116048_bib0048","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jbm.a.35277","article-title":"Escherichia coli adhesion, biofilm development and antibiotic susceptibility on biomedical materials","volume":"103","author":"Gomes","year":"2014","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116048_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijos.2014.65","article-title":"Strategies for combating bacterial biofilm infections","volume":"7","author":"Wu","year":"2015","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.diagmicrobio.2023.116048_bib0050","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10311-020-01169-5","article-title":"Development, dynamics and control of antimicrobial-resistant bacterial biofilms: a review","volume":"19","author":"Singh","year":"2021","journal-title":"Environ Chem Lett"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932300158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932300158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:59:59Z","timestamp":1760003999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288932300158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S073288932300158X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.116048","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.116048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116048"}}